Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05603481 · ClinicalTrials.gov registry record
CGM in Patients With ED's
A clinical trial of Avoidant Restrictive Food Intake Disorder and Anorexia Nervosa, Binge Eating/Purging Type, sponsored by Denver Health and Hospital Authority.
- Completed
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT05603481: Completed study of Avoidant Restrictive Food Intake Disorder and Anorexia Nervosa, Binge Eating/Purging Type, sponsored by Denver Health and Hospital Authority.
NCT05603481 is a study of Avoidant Restrictive Food Intake Disorder and Anorexia Nervosa, Binge Eating/Purging Type that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 50 participants, below the 4,043-participant average among 5 other Avoidant Restrictive Food Intake Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05603481, a study of Avoidant Restrictive Food Intake Disorder and Anorexia Nervosa, Binge Eating/Purging Type, has completed, sponsored by Denver Health and Hospital Authority.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the accuracy of continuous glucose monitoring (CGM) with point of care (POC) fingerstick glucose monitoring and venous blood glucose in patients with eating disorders, specifically anorexia nervosa, restricting subtype (AN-R); avoidant/restrictive food intake disorder (ARFID); and anorexia nervosa, binge/purge subtype (AN-BP).
Primary Outcome
To perform statical analysis to verify the accuracy of interstitial glucose measured via CGM as compared to the POC finger stick. In individuals with severe malnutrition, secondary to eating disorders
Conditions Studied
Interventions
- DEVICE Continuous Glucose Monitor
Study Locations (1)
Colorado
- Denver Health and Hospital Authority - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-05-09 |
| Est. Completion | 2024-07-02 |
What the finished NCT05603481 record still lists
NCT05603481 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 4,043-participant average among 5 other Avoidant Restrictive Food Intake Disorder trials with a reported enrollment target (99% lower).
The record links to 4 conditions, with Avoidant Restrictive Food Intake Disorder appearing as the primary indexed condition, and to 1 intervention - of which Continuous Glucose Monitor is the first listed.
NCT05603481 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT05603481 about?
NCT05603481 is a clinical study titled "CGM in Patients With ED's". To determine the accuracy of continuous glucose monitoring (CGM) with point of care (POC) fingerstick glucose monitoring and venous blood glucose in patients with eating disorders, specifically anorexia nervosa, restricting subtype (AN-R); avoidant/restrictive food intake disorder (ARFID); and anore...
What is the current status of trial NCT05603481?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2023-05-09. Estimated completion is 2024-07-02.
What conditions does trial NCT05603481 study?
This clinical trial studies the following conditions: Avoidant Restrictive Food Intake Disorder, Anorexia Nervosa, Binge Eating/Purging Type, Anorexia Nervosa, Restricting Type, ARFID.
What interventions are being tested in trial NCT05603481?
The interventions under investigation include: Continuous Glucose Monitor (DEVICE).
Who is sponsoring clinical trial NCT05603481?
This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05603481 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Avoidant Restrictive Food Intake Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Eating Disorders Genetics Initiative 2
RECRUITING
-
Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia
RECRUITING · NA
-
The Use of Cyproheptadine in Pediatric Feeding Disorders
ACTIVE NOT RECRUITING · Phase 4
-
Confirming the Efficacy/Mechanism of Family Therapy for Children With Low Weight ARFID
COMPLETED · NA
-
Evaluating Hunger Manipulation During Feeding Intervention
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI